Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) recently filed a Form 8-K with the Securities and Exchange Commission, detailing its financial performance for the third quarter of 2024. The company ...
Catalyst Pharmaceuticals Inc. (CPRX)股价飙升至52周新高,达到21.87美元,公司继续乘势上涨。这一峰值代表了该公司的一个重要里程碑,反映了其强劲的同比增长。过去一年,Catalyst Pharmaceuticals的股价上涨了62.05%,凸显了投资者的强烈信心和公司在制药行业的良好表现。52周新高证明了公司的战略举措及其在市场中持续增长的潜力。
Catalyst Pharma (CPRX) Company Description: Catalyst Pharmaceuticals is a biopharmaceutical company, which engages in the development and commercialization of therapies for people with rare ...